...
首页> 外文期刊>Journal of Reproductive Immunology >Pregnancy and postpartum levels of circulating maternal sHLA-G in preeclampsia
【24h】

Pregnancy and postpartum levels of circulating maternal sHLA-G in preeclampsia

机译:妊娠和产后产后水平循环母体Shla-g在Preclampsia

获取原文
获取原文并翻译 | 示例
           

摘要

Preeclampsia is a leading cause of maternal and offspring mortality and morbidity, and predicts increased future cardiovascular disease risk. Placental dysfunction and immune system dysregulation are likely key pathophysiological factors. Soluble human leukocyte antigen G (sHLA-G) may dampen the specific immune response towards placental trophoblasts. Previous studies have shown low sHLA-G levels in preeclampsia, but postpartum, levels are unknown. Furthermore, the relationship between sHLA-G and sFlt-1 and PlGF, placental function markers, is unknown. We hypothesized that low maternal sHLA-G during pregnancy would be associated with placental dysfunction, including preeclampsia, gestational hypertension, and dysregulated sFlt-1 and PlGF, and that sHLA-G would remain decreased following preeclampsia.
机译:先兆子痫是导致母婴死亡率和发病率的主要原因,预示着未来心血管疾病风险的增加。胎盘功能障碍和免疫系统失调可能是关键的病理生理因素。可溶性人白细胞抗原G(sHLA-G)可能会抑制胎盘滋养层的特异性免疫反应。此前的研究表明,先兆子痫患者体内sHLA-G水平较低,但产后sHLA-G水平尚不清楚。此外,sHLA-G和sFlt-1以及胎盘功能标志物PlGF之间的关系尚不清楚。我们假设孕期母体sHLA-G水平较低与胎盘功能障碍有关,包括先兆子痫、妊娠高血压、sFlt-1和PlGF失调,且先兆子痫后sHLA-G水平仍将降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号